-
Tailoring treatment and follow-up strategies of patients with cervical adenocarcinoma in situ and cervical cancer
Schaafsma, M., 23 Feb 2026, 268 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Optimal follow-up strategy using high-risk human papillomavirus testing and cytology after conservative treatment for cervical adenocarcinoma in situ
Schaafsma, M., Schuurman, T. N., van Maurik, I. S., Bekkers, R. L. M., Zusterzeel, P. L. M., Bleeker, M. C. G., Siebers, A. G., Mom, C. H., Berkhof, J. & van Trommel, N. E., Nov 2025, In: American journal of obstetrics and gynecology. 233, 5, p. 459.e1-459.e17Research output: Contribution to journal › Article › Academic › peer-review
-
The risk for residual AIS/CIN3+ after the first conservative surgical procedure for cervical adenocarcinoma in situ – A Dutch retrospective cohort study
Schaafsma, M., Schuurman, T. N., Bekkers, R. L. M., Dunné, F.R.-V., Verhoeve, H. R., Zusterzeel, P. L. M., Bleeker, M. C. G., Mom, C. H., Siebers, A. G., Berkhof, J. & van Trommel, N. E., 1 Sept 2025, In: Gynecologic Oncology. 200, p. 44-50 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
